Nuformix plc (LON:NFX – Get Free Report)’s stock price rose 17.6% on Friday . The company traded as high as GBX 0.31 and last traded at GBX 0.30. Approximately 22,581,281 shares were traded during mid-day trading, a decline of 57% from the average daily volume of 53,071,184 shares. The stock had previously closed at GBX 0.26.
Nuformix Stock Up 5.9%
The company has a market capitalization of £5.70 million, a price-to-earnings ratio of -0.69 and a beta of 1.22. The company’s 50 day simple moving average is GBX 0.29 and its two-hundred day simple moving average is GBX 0.18.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications.
Featured Articles
- Five stocks we like better than Nuformix
- Buy this $2 Gold Stock Before January 1, 2026
- Do not delete, read immediately
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
